BIOLOGICSMD
BiologicsMD™ is an early stage therapeutic development company focused on developing highly-targeted or ‘smart’ therapies for the treatment of hair loss diseases and conditions, as well as severe bone disorders. The company is developing a series of recombinant fusion proteins that provide powerful stimulatory effects directly to the target receptors at the point of disease – and do so with sustained therapeutic exposure in either a single dose or very infrequent dosing regimens. The company is working on formulation and delivery vehicles that can accommodate parenteral, local, and topical administration.
BIOLOGICSMD
Social Links:
Industry:
Biotechnology
Founded:
2009-01-01
Address:
Fayetteville, Arkansas, United States
Country:
United States
Website Url:
http://www.biologicsmd.com
Total Employee:
1+
Status:
Active
Contact:
479.521.1997
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Global Site Tag Euro US Privacy User Signal Mechanism
Similar Organizations
Crescita Therapeutics
Crescita Therapeutics is a drug development company.
Current Employees Featured
Official Site Inspections
http://www.biologicsmd.com
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "BiologicsMD"
Overview — BiologicsMD, Inc.
The CompanyBiologicsMD, Inc. BiologicsMD™ is an early stage therapeutic development company focused on developing highly-targeted treatments for hair loss diseases and …See details»
BiologicsMD - Crunchbase Company Profile & Funding
BiologicsMD™ is an early stage therapeutic development company focused on developing highly-targeted or ‘smart’ therapies for the treatment of hair loss diseases and conditions, as well as severe bone disorders.See details»
BiologicsMD, Inc. - LinkedIn
BiologicsMD is developing novel therapeutics and therapeutic-device combinations for the treatment of hair-loss and bone disorders. The company's portfolio of hair cycle stimulators (HCS) are ...See details»
BiologicsMD - 2025 Company Profile & Team - Tracxn
Jul 10, 2025 BiologicsMD - Developing fusion proteins for Alopecia areata (hair loss) and bone disorders. Raised a total funding of $400K over 4 rounds from 5 investors.See details»
BiologicsMD 2025 Company Profile: Valuation, Funding …
Information on valuation, funding, cap tables, investors, and executives for BiologicsMD. Use the PitchBook Platform to explore the full profile.See details»
BiologicsMD - BioCT
BiologicsMD’s lead asset, BMD-1141, is a patent-protected, first-in-class hair cycle stimulator for the treatment of various types of non-scarring alopecia including alopecia areata, …See details»
BiologicsMD, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore BiologicsMD, Inc. with its drug pipeline, therapeutic area, technology platform, 2 news, Disease Domain:Neoplasms, Technology Platform:Antibody fusion ...See details»
BiologicsMD, Inc.
BiologicsMD™ is a Preclinical Therapeutic Company Focused on Developing Highly-Targeted Parathyroid Hormone Receptor-Mediated Treatments for Hair Loss, Bone Disorders and …See details»
BiologicsMD, Inc Company Profile | Fayetteville, AR | Competitors ...
Find company research, competitor information, contact details & financial data for BiologicsMD, Inc of Fayetteville, AR. Get the latest business insights from Dun & Bradstreet.See details»
BiologicsMD - Craft
BiologicsMD has 5 employees across 2 locations. See insights on BiologicsMD including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Intro — BiologicsMD, Inc.
BiologicsMD™ is a Preclinical Therapeutic Company Focused on Developing Highly-Targeted Parathyroid Hormone Receptor-Mediated Treatments for Hair Loss, Bone Disorders and …See details»
BiologicsMD: Targeted Treatments for Bone Disorders and Hair Loss
Aug 16, 2022 J. David Owens, President & CEO of BiologicsMD, & CSO Dr. Robyn Goforth discuss the Company’s highly-targeted therapies, a series of recombinant fusion proteins …See details»
BiologicsMD - Funding, Financials, Valuation & Investors
BiologicsMD is a therapeutic development company.in funding over 2 rounds. Their latest funding was raised on May 16, 2024 from a Corporate Round round.See details»
BiologicsMD - VIC Network
BiologicsMD is developing highly targeted, novel human therapeutics for hair loss diseases and conditions, as well as severe bone disorders. The company’s portfolio of hair cycle stimulators …See details»
Microsoft Word - 2016 04 26 BioMD Executive Summary.docx
Company Overview BiologicsMD was founded in 2010 to develop highly-‐targeted, novel human therapeutics for the treatment of hair loss diseases and conditions, as well as severe bone …See details»
Board of Directors — BiologicsMD, Inc.
David Scheer Mr. David Scheer is the founder and President of Scheer & Company, which provides strategic and transactional advisory services to companies in the life sciences …See details»
BiologicsMD - Contacts, Employees, Board Members, Advisors
BiologicsMD is a therapeutic development company.See details»
News — BiologicsMD, Inc.
AUGUST 2013 BiologicsMD, Inc. Announces the Appointment of J. David Owens as Chief Executive Officer JULY 2013 BiologicsMD, Inc. Awards Manufacturing Contract to Cytovance …See details»
Technology Pipeline — BiologicsMD, Inc.
A Portfolio of Highly-Targeted Parathyroid Hormone Receptor-Mediated Treatments Technology Technology Pipeline Alopecia Bone Disorders Scientific PublicationsSee details»
Business Advisors — BiologicsMD, Inc.
Business Advisors Sarah Faust Sarah Faust brings over 30 years of US and global pharmaceutical and biotech industry experience to the BiologicsMD Advisory Team. With a …See details»